I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Adjuvant therapy with anti-PD-1 antibody vs targeted therap..:
LI Ting
;
XU Yu
;
JIA Dongdong
...
http://www.china-oncology.com/fileup/1007-3639/PDF/1675314908142-143848152.pdf. , 2022
Link:
https://doi.org/10.19401/j.cnki.1007-3639.2022.12.002
RT Journal T1
Adjuvant therapy with anti-PD-1 antibody vs targeted therapy for patients with resected stage Ⅲ malignant melanoma: a real-world data analysis from China centers
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:5bf42567c5124ebd8a03c182416525a2&Exemplar=1&LAN=DE A1 LI Ting A1 XU Yu A1 JIA Dongdong A1 LIAO Zhichao A1 SUN Wei A1 WU Haixiao A1 REN Zhiwu A1 ZHAO Jun A1 XING Ruwei A1 TENG Sheng A1 YANG Yun A1 CHEN Yong A1 LI Tao A1 YANG Jilong PB Editorial Office of China Oncology YR 2022 K1 |melanoma|adjuvant therapy|anti-programmed death-1 therapy|braf mutation|recurrence-free survival K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://www.china-oncology.com/fileup/1007-3639/PDF/1675314908142-143848152.pdf LK http://dx.doi.org/https://doi.org/10.19401/j.cnki.1007-3639.2022.12.002 DO https://doi.org/10.19401/j.cnki.1007-3639.2022.12.002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)